Press release

Meet the Bilcare Research Global Pharma Team at CPhI China Booth W5G32 | Shanghai New Int’l Expo Center (SNIEC)| China

Bilcare_Platzhalter_EN
Share on facebook
Share on twitter
Share on linkedin
Share on xing
Share on whatsapp
Share on email

Download the Press release

Bilcare Research’s Global Pharma Team will be exhibiting at the CPhI China, June 20th – 22nd 2017. They will share the latest developments in its offer to the pharmaceutical packaging market and demonstrate innovative packaging solution. Besides packaging materials, Bilcare Research offers its expertise in packaging design and drug delivery systems: From Packaging to Blister Solutions. – Innovation is in our DNA.

This Shanghai CPHI is another step to be closer to their Chinese customers. Bilcare Research offers the global Pharmaceutical industry high quality of all available barrier films with the same properties and specifications – wherever customers are located. Bilcare Research Chinese technical and commercial team are able to quickly response and provide support to their customer to fully utilize Bilcare Research technology, products and services.

Bilcare Research will also organize an exclusive technical seminar for their customers during CPHI on June 21st, it will share the latest update of CFDA regulation on pharmaceutical packaging. Bilcare team of experts will provide an in-depth information about BilcareOptimaTM, all about avoiding extensive trial and cost, finding the right packaging and material. Customers will be informed about this winning formula for faster speed-to-market and reduction of packaging cost, as well as about Bilcare Academy and technical support.

BilcareOptimaTM, this groundbreaking, independent study examines the degradation of an unpackaged product under influence of various environmental factors, such as humidity, temperature, light and oxygen, which enables customers to define the perfect packaging material for their products. BilcareOptimaTM identifies drug’s optimal packaging materials while balancing cost and barrier-protection requirements, avoids trial-and-error approach to drug testing, and therefore, significantly reduces time to market and stability test costs.

The production sites for pharmaceutical blister packaging films deliver uniform quality – whether produced in Europe, US or in Asia. The acquisition in coating capacity in Asia, the recently finalized installation in a new laminator in US and as well as the capacity increase in Europe are part of a strategic investment program and show the dedication to the Pharmaceutical industry.

“The CPhI exhibitions around the globe are often considered as leading events in the pharma packaging & drug delivery industry. Joining the exhibition in Shanghai shows Bilcare Research’s focus on it’s customers producing in China or for the Chinese market already” said Andreas Pfefferle, BU Head Global PPI. “We are also looking forward to providing solutions to new Chinese customers and build up strong relationships with them”.

Scroll to Top